AstraZeneca, Microsoft, Adidas: Intellectual Property

AstraZeneca Plc lost an appeals court ruling yesterday that clears sales by South Korea’s Hanmi Pharm Co. of a competing copy of the heartburn treatment Nexium.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.